Riley Bove

Known for influential publications on neurodegenerative diseases, Riley Bove is an esteemed Associate Professor of Neurology at the UCSF Weill Institute for Neurosciences. As a dedicated member of the Ann S. Bowers Women's Brain Health Initiative, Riley's work is at the forefront of understanding and combating the molecular underpinnings of neurotoxicity. Their research is pivotal in developing neurotherapeutics aimed at mitigating the progression of debilitating conditions such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer's disease. Riley's academic journey has been marked by a profound commitment to unraveling the complexities of neurodegeneration. Their work is characterized by a multidisciplinary approach, integrating insights from molecular biology, genetics, and clinical studies to explore innovative therapeutic strategies. This comprehensive approach not only advances scientific understanding but also holds promise for improving patient outcomes in neurodegenerative disorders. At the Psychological and Brain Sciences University of California-Santa Barbara, Riley collaborates with a diverse team of researchers, fostering an environment of intellectual curiosity and innovation. Their contributions to the field are not only recognized through numerous publications but also through their active participation in international conferences and symposiums, where they share insights and collaborate with fellow experts. In addition to their research endeavors, Riley is deeply committed to mentoring the next generation of scientists. They are passionate about guiding students and young researchers, encouraging them to pursue careers in neuroscience and contribute to the growing body of knowledge in neurodegenerative diseases. Through their mentorship, Riley aims to inspire a new wave of researchers dedicated to finding solutions for these challenging conditions.